Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine Hydrochloride in Neurogenic Orthostatic Hypotension
NCT00046475Phase 4Completed
- Sponsor
- Takeda
- Start
- Dec 1997
- Primary completion
- Nov 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of midodrine in Neurogenic Orthostatic Hypotension (nOH), sponsored by Takeda. Started Dec 1997; status: completed.
02
Drugs
midodrine
03
Conditions
Neurogenic Orthostatic Hypotension (nOH)
Beyond the preview
Go deeper on NCT00046475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00046475.